Skip to main content
Erschienen in: Lasers in Medical Science 4/2016

28.01.2016 | Original Article

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up

verfasst von: Gang Wu, Zhe Hong, Chao Li, Cuidong Bian, Shengsong Huang, Denglong Wu

Erschienen in: Lasers in Medical Science | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to compare the efficacy and safety of diode laser enucleation of the prostate (DiLEP) with plasmakinetic enucleation of the prostate (PKEP) for symptomatic benign prostatic hyperplasia (BPH) patients with large prostate (volume > 80 ml). From January 2013 to June 2014, 80 consecutive patients were randomized treated with DiLEP (n = 40) or PKEP (n = 40). Perioperative and postoperative outcome data were assessed during a 1-year follow-up. There were no significant preoperative differences between the two surgical groups. The mean prostate volumes in the DiLEP and PKEP groups were 98.6 and 93.3 ml, respectively. DiLEP was equivalent to PKEP in improvement in International Prostate Symptom Score (IPSS), quality of life scores, and maximum flow rate. Compared with PKEP, patients treated with DiLEP showed a lower risk of blood loss (P < 0.01), shorter bladder irrigation and catheterization times (P < 0.01), as well as shorter hospital stays (P < 0.01). Moreover, the DiLEP group was significantly superior to bipolar plasmakinetic group in the irritative symptoms. However, the operation time of the DiLEP group was longer than that of PKEP group (P = 0.02). Both DiLEP and PKEP are safe and effective methods for the treatment of BPH in large prostates (volume > 80 ml). Compared with PKEP, DiLEP provides a decreased risk of hemorrhage, reduced bladder irrigation, and catheterization times, as well as shorter hospital stays.
Literatur
1.
Zurück zum Zitat Bushman W (2009) Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin N Am 36:403–415CrossRef Bushman W (2009) Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin N Am 36:403–415CrossRef
2.
Zurück zum Zitat Bhansali M, Patankar S, Dobhada S et al (2009) Management of large (>60 g) prostate gland: PlasmaKinetic superpulse (bipolar) versus conventional (monopolar) transurethral resection of the prostate. J Endourol 23:141–145CrossRefPubMed Bhansali M, Patankar S, Dobhada S et al (2009) Management of large (>60 g) prostate gland: PlasmaKinetic superpulse (bipolar) versus conventional (monopolar) transurethral resection of the prostate. J Endourol 23:141–145CrossRefPubMed
3.
Zurück zum Zitat Cornu JN, Ahyai S, Bachmann A et al (2014) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed Cornu JN, Ahyai S, Bachmann A et al (2014) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed
4.
Zurück zum Zitat Kavanagh LE, Jack GS, Lawrentschuk N (2011) Prevention and management of TURP-related hemorrhage. Nat Rev Urol 8:504–514CrossRefPubMed Kavanagh LE, Jack GS, Lawrentschuk N (2011) Prevention and management of TURP-related hemorrhage. Nat Rev Urol 8:504–514CrossRefPubMed
5.
Zurück zum Zitat Alschibaja M, May F, Treiber U et al (2006) Recent improvements in transurethral high-frequency electrosurgery of the prostate. BJU Int 97:243–246CrossRefPubMed Alschibaja M, May F, Treiber U et al (2006) Recent improvements in transurethral high-frequency electrosurgery of the prostate. BJU Int 97:243–246CrossRefPubMed
6.
Zurück zum Zitat Wendt-Nordahl G, Huckele S, Honeck P et al (2007) 980-nm diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52:1723–1728CrossRefPubMed Wendt-Nordahl G, Huckele S, Honeck P et al (2007) 980-nm diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 52:1723–1728CrossRefPubMed
7.
Zurück zum Zitat Wezel F, Wendt-Nordahl G, Huck N et al (2010) New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device. World J Urol 28:181–186CrossRefPubMed Wezel F, Wendt-Nordahl G, Huck N et al (2010) New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device. World J Urol 28:181–186CrossRefPubMed
8.
Zurück zum Zitat Xu A, Zou Y, Li B et al (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27:1254–1260CrossRefPubMed Xu A, Zou Y, Li B et al (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27:1254–1260CrossRefPubMed
9.
Zurück zum Zitat Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140CrossRefPubMed Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140CrossRefPubMed
10.
Zurück zum Zitat Pfitzenmaier J, Gilfrich C, Pritsch M et al (2008) Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int 102:322–327CrossRefPubMed Pfitzenmaier J, Gilfrich C, Pritsch M et al (2008) Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int 102:322–327CrossRefPubMed
11.
Zurück zum Zitat Tan AH, Gilling PJ, Kennett KM et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170:1270–1274CrossRefPubMed Tan AH, Gilling PJ, Kennett KM et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170:1270–1274CrossRefPubMed
12.
Zurück zum Zitat Chen YB, Chen Q, Wang Z et al (2013) A prospective, randomized clinical trial comparing plasmakinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year follow up. J Urol 189:217–222CrossRefPubMed Chen YB, Chen Q, Wang Z et al (2013) A prospective, randomized clinical trial comparing plasmakinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year follow up. J Urol 189:217–222CrossRefPubMed
13.
Zurück zum Zitat Neill MG, Gilling PJ, Kennett KM et al (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68:1020–1024CrossRefPubMed Neill MG, Gilling PJ, Kennett KM et al (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68:1020–1024CrossRefPubMed
14.
Zurück zum Zitat Liao N, Yu J (2012) A study comparing plasmakinetic enucleation with bipolar plasmakinetic resection of the prostate for benign prostatic hyperplasia. J Endourol 26:884–888CrossRefPubMed Liao N, Yu J (2012) A study comparing plasmakinetic enucleation with bipolar plasmakinetic resection of the prostate for benign prostatic hyperplasia. J Endourol 26:884–888CrossRefPubMed
15.
Zurück zum Zitat Naspro R, Suardi N, Salonia A et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568CrossRefPubMed Naspro R, Suardi N, Salonia A et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568CrossRefPubMed
16.
Zurück zum Zitat Liu C, Zheng S, Li H et al (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184:2440–2445CrossRefPubMed Liu C, Zheng S, Li H et al (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184:2440–2445CrossRefPubMed
17.
Zurück zum Zitat Zhao Z, Zeng G, Zhong W et al (2010) A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol 58:752–758CrossRefPubMed Zhao Z, Zeng G, Zhong W et al (2010) A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol 58:752–758CrossRefPubMed
18.
Zurück zum Zitat Chen CH, Chiang PH, Lee WC et al (2012) High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml). Lasers Surg Med 44:699–704CrossRefPubMed Chen CH, Chiang PH, Lee WC et al (2012) High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml). Lasers Surg Med 44:699–704CrossRefPubMed
19.
Zurück zum Zitat Kaplan SA (2014) Re: high-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostate (>80 ml). J Urol 191:743CrossRefPubMed Kaplan SA (2014) Re: high-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostate (>80 ml). J Urol 191:743CrossRefPubMed
20.
Zurück zum Zitat Shaker HS, Saafan A, Yassin MM et al (2015) Safety and efficacy of quartz head contact laser ablation for large prostates using 980-nm laser: a comparative prospective study against that for small- and medium-sized prostates. Urology 85:452–456CrossRefPubMed Shaker HS, Saafan A, Yassin MM et al (2015) Safety and efficacy of quartz head contact laser ablation for large prostates using 980-nm laser: a comparative prospective study against that for small- and medium-sized prostates. Urology 85:452–456CrossRefPubMed
21.
Zurück zum Zitat Yang SS, Hsieh CH, Chiang IN et al (2013) Prostate volume did not affect voiding function improvements in diode laser enucleation of the prostate. J Urol 189:993–998CrossRefPubMed Yang SS, Hsieh CH, Chiang IN et al (2013) Prostate volume did not affect voiding function improvements in diode laser enucleation of the prostate. J Urol 189:993–998CrossRefPubMed
22.
Zurück zum Zitat Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12:277–280CrossRefPubMed Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12:277–280CrossRefPubMed
23.
Zurück zum Zitat Chen CH, Chiang PH, Chuang YC et al (2010) Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 75:658–663CrossRefPubMed Chen CH, Chiang PH, Chuang YC et al (2010) Preliminary results of prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-W high-intensity diode laser. Urology 75:658–663CrossRefPubMed
24.
Zurück zum Zitat Netsch C, Bach T, Pohlmann L et al (2012) Comparison of 120–200 W 2 mum thulium:yttrium-aluminum-garnet vapoenucleation of the prostate. J Endourol 26:224–229CrossRefPubMed Netsch C, Bach T, Pohlmann L et al (2012) Comparison of 120–200 W 2 mum thulium:yttrium-aluminum-garnet vapoenucleation of the prostate. J Endourol 26:224–229CrossRefPubMed
25.
Zurück zum Zitat Netsch C, Pohlmann L, Herrmann TR et al (2012) 120-W 2-microm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up. BJU Int 110:96–101CrossRefPubMed Netsch C, Pohlmann L, Herrmann TR et al (2012) 120-W 2-microm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up. BJU Int 110:96–101CrossRefPubMed
Metadaten
Titel
A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up
verfasst von
Gang Wu
Zhe Hong
Chao Li
Cuidong Bian
Shengsong Huang
Denglong Wu
Publikationsdatum
28.01.2016
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 4/2016
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-016-1883-1

Weitere Artikel der Ausgabe 4/2016

Lasers in Medical Science 4/2016 Zur Ausgabe